Shionogi: all 157 studies

Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess S-309309 in Healthy and Obese ParticipantsCompletedNCT05247970Phase 1
• A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X SyndromeCompletedNCT05163808Phase 2/3
• Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult SubjectsCompletedNCT05072444Phase 1
• SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy VolunteersCompletedNCT04808414Phase 1
• Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler DeviceCompletedNCT04631354Phase 1
• Women's Satisfaction and Adherence to Vulvovaginal Atrophy TreatmentsCompletedNCT04607707
• Phase 1 Oral QPX7831 SAD and MAD in Healthy AdultsCompletedNCT04578873Phase 1
• P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHVCompletedNCT04380207Phase 1
• First-in-human Study of S-588210 (S-488210+S-488211)CompletedNCT04316689Phase 1
• Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)CompletedNCT04259255
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric ParticipantsCompletedNCT04215991Phase 2
• A Phase 1, Open-Label, PET Study of T2310 & BPN14770WithdrawnNCT04044781Phase 1
• Phase 1 Study of Oral QPX2015 in Healthy Adult SubjectsCompletedNCT03939429Phase 1
• Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult VolunteersCompletedNCT03897413Phase 1
• Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial HypertensionWithdrawnNCT03789643Phase 2
• Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial InfectionsApproved for marketingNCT03780140
• Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy VolunteersCompletedNCT03030105Phase 1
• Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis SubjectsCompletedNCT03018509Phase 1
• A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female SubjectsCompletedNCT02840279Phase 1
• Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on HemodialysisCompletedNCT02805244Phase 1
• BPN14770 Single Ascending Dose Study in Healthy Male and Female SubjectsCompletedNCT02648672Phase 1
• Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal DiseaseCompletedNCT02581124Phase 1
• A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or OlderCompletedNCT02366962Phase 3
• Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252TerminatedNCT02120976Phase 1
• Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic SubjectsCompletedNCT02106585Phase 1
• Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal DiseaseCompletedNCT01978587Phase 1
• Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal DiseaseCompletedNCT01971164Phase 1
• A Study to Evaluate Intramuscular ASP7374CompletedNCT01961960Phase 3
• Study of ASP7374, Cell-culture-derived Influenza VaccineCompletedNCT01961947Phase 3
• Phase-3 Study of ASP7374, Cell-culture-derived Influenza VaccineCompletedNCT01767896Phase 3
• Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes MellitusCompletedNCT01699737Phase 2
• Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic RhinitisCompletedNCT01651871Phase 2
• Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy SubjectsCompletedNCT01475981Phase 1
• Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy SubjectsTerminatedNCT01473069Phase 1
• Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected SubjectsCompletedNCT01473056Phase 1
• A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult VolunteersCompletedNCT01450579Phase 2
• A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult VolunteersCompletedNCT01393951Phase 1/2
• Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin TherapyCompletedNCT01240759Phase 2
• Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed AdultsCompletedNCT01195038Phase 2
• Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT01154348Phase 1
• Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese SubjectsCompletedNCT01126970Phase 2
• Efficacy and Safety Study of JTT-654 in Type 2 Diabetic PatientsTerminatedNCT00997152Phase 2
• Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young AdultsCompletedNCT00980447Phase 2
• Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic PatientsCompletedNCT00929539Phase 2
• Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese SubjectsCompletedNCT00788528Phase 2
• Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C LevelsCompletedNCT00749788Phase 2
• Safety Study of JTT-302 in Subjects With Low HDL-C LevelsCompletedNCT00748852Phase 2
• Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie DietCompletedNCT00748605Phase 2
• Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie DietCompletedNCT00747929Phase 2
• A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic DermatitisCompletedNCT00703573Phase 2
• A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic DermatitisCompletedNCT00697710Phase 1/2
• Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsCompletedNCT00689442Phase 2
• Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II HyperlipidemiaCompletedNCT00688896Phase 2
• Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsCompletedNCT00688558Phase 2
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined HyperlipidemiaCompletedNCT00459745Phase 3
• Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerCompletedNCT00078390Phase 1/2
• A Phase 1 Study of S-3304 in Patients With Solid TumorsCompletedNCT00033215Phase 1

← Shionogi overview and focus areas